A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)

Clinical trial NCT04129619 · COMPLETED

Trial details

NCT number: NCT04129619
Sponsor: OrphoMed, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Diarrhea

Start date: 2019-11-22
Primary completion: 2021-10-04
Enrollment: 321

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.